(Q36331864)

13 August 2017

1 reference

title

Sex differences in antiretroviral therapy-associated intolerance and adverse events (English)

1 reference

13 August 2017

anti-retroviral agent

0 references

author name string

Rebecca Clark

series ordinal

1

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

28

1 reference

13 August 2017

1075-1083

1 reference

13 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200528120-00003

13 August 2017

0 references

cites work

Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women

1 reference

12 December 2020

Antiretroviral therapy in drug-naive patients infected with human immunodeficiency virus

1 reference

12 December 2020

Sex differences in adverse reactions to antiretroviral drugs.

1 reference

12 December 2020

Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.

1 reference

12 December 2020

Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team

1 reference

12 December 2020

Sex differences in nevirapine rash

1 reference

12 December 2020

Pharmacokinetics of ethynyl estradiol: a current view.

1 reference

12 December 2020

Adverse events from drug therapy for human immunodeficiency virus disease

1 reference

12 December 2020

Body habitus changes related to lipodystrophy

1 reference

12 December 2020

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

1 reference

12 December 2020

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

1 reference

12 December 2020

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

12 December 2020

Zidovudine pharmacokinetics in HIV-positive women during different phases of the menstrual cycle.

1 reference

12 December 2020

Nelfinavir plasma concentrations are low during pregnancy

1 reference

12 December 2020

Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women

1 reference

12 December 2020

Unexpected drug interactions and adverse events with antiretroviral drugs

1 reference

12 December 2020

Intracellular pharmacology of nucleoside analogues and protease inhibitors: role of transporter molecules

1 reference

12 December 2020

Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women

1 reference

12 December 2020

Population pharmacokinetic meta-analysis with efavirenz

1 reference

12 December 2020

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study

1 reference

12 December 2020

Liver disease in pregnancy and fetal fatty acid oxidation defects

1 reference

12 December 2020

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

1 reference

12 December 2020

Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022.

1 reference

12 December 2020

Gender-specific considerations in the antiretroviral management of HIV-infected women

1 reference

12 December 2020

Sex differences in nevirapine rash

1 reference

12 December 2020

Lactic acidosis in HIV infected patients: a systematic review of published cases

1 reference

12 December 2020

Oral contraception does not alter single dose saquinavir pharmacokinetics in women

1 reference

12 December 2020

Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs

1 reference

12 December 2020

Sex differences in pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women

1 reference

12 December 2020

Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators

1 reference

12 December 2020

The relationship between nevirapine plasma concentrations and abnormal liver function tests

1 reference

12 December 2020

Sex differences in HAART-associated dyslipidaemia

1 reference

12 December 2020

Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: pharmacokinetics and efficacy.

1 reference

12 December 2020

Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals

1 reference

12 December 2020

10.2165/00002018-200528120-00003

Identifiers

DOI

1 reference

PubMed ID

16329711

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16329711